Montelukast treatment of moderate to severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled trial
- 31 July 2005
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 53 (1) , 147-149
- https://doi.org/10.1016/j.jaad.2004.12.011
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Efficacy and Tolerability of Montelukast as a Therapeutic Agent for Severe Atopic Dermatitis in AdultsActa Dermato-Venereologica, 2002
- Montelukast in the treatment of children with moderate‐to‐severe atopic dermatitis: A pilot studyPediatric Allergy and Immunology, 2001
- The eczema area and severity index (EASI): assessment of reliability in atopic dermatitisExperimental Dermatology, 2001
- The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitisJournal of the American Academy of Dermatology, 2001
- The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis.Archives of Dermatology, 1998
- Diagnostic Features of Atopic DermatitisActa Dermato-Venereologica, 1980